Concord Wealth Partners 9 Meters Biopharma, Inc. Call Options Transaction History
Concord Wealth Partners
- $591 Million
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NMTR
# of Institutions
3Shares Held
67.9KCall Options Held
0Put Options Held
0About 9 METERS BIOPHARMA, INC.
- Ticker NMTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,955,400
- Market Cap $259K
- Description
- 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...